Why does the burden of disease persist? Relating the burden of anxiety and depression to effectiveness of treatment

Author(s): Andrews G, Sanderson K, Slade T, Issakidis C

Abstract

Why does the burden of mental disorders persist in established market economies? There are four possibilities: the burden estimates are wrong; there are no effective treatments; people do not receive treatment; or people do not receive effective treatments. Data from the Australian National Survey of Mental Health and Wellbeing about the two commonest mental disorders, generalized anxiety disorder and depression, have been used in examining these issues. The burden of mental disorders in Australia is third in importance after heart disease and cancer, and anxiety and depressive disorders account for more than half of that burden. The efficacy of treatments for both disorders has been established. However, of those surveyed, 40% with current disorders did not seek treatment in the previous year and only 45% were offered a treatment that could have been beneficial. Treatment was not predictive of disorders that remitted during the year. The burden therefore persists for two reasons: too many people do not seek treatment and, when they do, efficacious treatments are not always used effectively.

Similar Articles

Anxiety and Its Disorders

Author(s): Barlow DH

The anxiolytic-like effects of Aloysia polystachya (Griseb

Author(s): Hellión-Ibarrola MC, Ibarrola DA, Montalbetti Y, Kennedy ML, Heinichen O, et al.

The encyclopedia of essential oils

Author(s): Lawless J

Anxiolytic effects of lavender oil inhalation on open-field behaviour in rats

Author(s): Shaw D, Annett JM, Doherty B, Leslie JC

Anxiolytic-like effects of rose oil inhalation on the elevated plus-maze test in rats

Author(s): Almeida RN, Motta SC, Faturi CB, Catallani B, Leite JR

Effects of the essential oil from Citrus aurantium L

Author(s): Pultrini AM, Galindo LA, Costa M

Interspecies comparison of chemical composition and anxiolytic-like effects of lavender oils upon inhalation

Author(s): Takahashi M, Satou T, Ohashi M, Hayashi S, Sadamoto K, et al.

Effects of inhaled Linalool in anxiety, social interaction and aggressive behavior in mice

Author(s): Linck VM, da Silva AL, Figueiró M, Caramão EB, Moreno PR, et al.

Anxiolytic-like effect of the monoterpene 1,4-cineole in mice

Author(s): Gomes PB, Feitosa ML, Silva MI, Noronha EC, Moura BA, et al.

Anxiolytic-like effect of Carvacrol (5-isopropyl-2-methylphenol) in mice: involvement with GABAergic transmission

Author(s): Melo FH, Venâncio ET, de Sousa DP, de França Fonteles MM, de Vasconcelos SM, et al.

Central nervous system activity of acute administration of isopulegol in mice

Author(s): Silva MI, de Aquino Neto MR, Teixeira Neto PF, Moura BA, do Amaral JF, et al.

Anxiolytic-like effect of sweet orange aroma in Wistar rats

Author(s): Faturi CB,Leite JR,Alves PB,Canton AC,Teixeira-Silva F

Effect of sweet orange aroma on experimental anxiety in humans

Author(s): Goes TC,Antunes FD,Alves PB,Teixeira-Silva F